Both in Biotechnology
INmune Bio vs Aligos Therapeutics
Over the past year INMB returned −33.6% and ALGS returned −38.5%; their daily moves had a correlation of 0.29.
INMB −33.6% ALGS −38.5%Growth of $1, one year, split-adjusted
| Metric | INMB | ALGS |
|---|---|---|
| Price | $1.18 | $4.51 |
| Market cap | $36.4M | $28.2M |
| Today | −11.65% | −10.16% |
| 1 month | −36.8% | −15.2% |
| 6 months | −17.8% | −25.2% |
| Year to date | −24.7% | −51.6% |
| 1 year | −31.7% | −37.4% |
| Revenue growth (YoY) | — | +2778.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −5.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.9× |
| Net cash | $18.4M | $30.3M |
| Dividend yield | — | — |
| Volatility (60d) | 69.5% | 68.5% |
| Short % of float | 11.7% | 12.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).